Breaking News | Fact Sheet: Free Radicals, Antioxidants And Medical Myths thestreetjournal.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestreetjournal.org Daily Mail and Mail on Sunday newspapers.
Published: May 10, 2021
(
Copenhagen, May 10, 2021). ZERION Pharma, a Danish pharmaceutical company, elected two new members Dr. Torsten Goesch and Dr. Lars Lykke Thomsen to join its board of directors at the annual general meeting held on May 6, 2021.
Dr. Torsten Goesch is an experienced life science venture capital investor and has been a partner and director at Rosetta Capital since 2002. Dr. Goesch is also the founder and former managing director of TRG invest, a Munich-based consultancy serving companies in the life science sector. Prior to his role at Rosetta capital he was the general manager of Biogen in Europe from 1997 to 1999 and before this he was the commercial head of Merck KGaA’s generic drug business, Merck Generics. He brings a wealth of experience to the role, having served on the board of many notable biopharmaceutical companies including Enobia Ltd, Cytochroma Ltd and the Danish company Forward Pharma. Dr. Goesch is a physician by training and holds an
Heinrich-Heine University Duesseldorf
How can a highly effective drug be transported to the precise location in the body where it is needed? In the journal Angewandte Chemie, chemists at Heinrich Heine University Düsseldorf (HHU) together with colleagues in Aachen present a solution using a molecular cage that opens through ultrasonification.
Supramolecular chemistry involves the organization of molecules into larger, higher-order structures. When suitable building blocks are chosen, these systems ‘self-assemble’ from their individual components.
Certain supramolecular compounds are well suited for ‘host-guest chemistry’. In such cases, a host structure encloses a guest molecule and can shield, protect and transport it away from its environment. This is a specialist field of Dr. Bernd M. Schmidt and his research group at the Institute of Organic and Macromolecular Chemistry at HHU.
April 30, 2021
Plant scientists in the U.S. and Germany are partnering to exchange ideas that could transform agriculture, through student exchange and a newly launched seminar series.
Plant scientists at Washington State University and in Germany will launch a new research collaboration through a series of virtual talks about advances that help feed and sustain our world, starting Tuesday, May 4.
The WSU-Germany partnership developed over the last several years to support the exchange of ideas and students and now includes a biweekly series of seminars delivered by pairs of WSU faculty and their counterparts at Germany’s CEPLAS, the Cluster of Excellence on Plant Sciences.
Share this article
BOHEMIA, N.Y. and PITTSBURGH, April 30, 2021 /PRNewswire/ Scientific Industries, Inc. (OTCQB: SCND)
today announced the appointment of Dr. Jürgen Schumacher to the Company s Board of Directors.
Dr. Jürgen Schumacher is an internationally recognized German entrepreneur with more than 35 years of expertise in the biotech industry. Dr. Schumacher co-founded Qiagen AG, one of Germany s largest biotechnology companies, NewLab Bioquality AG, which was acquired by Charles River Laboratories International Inc., BiBiTech and Algiax Pharmaceuticals. Dr. Schumacher advises and invests in promising biotech business models.
Dr. Schumacher holds a PhD in Biology from Heinrich Heine University of Düsseldorf and a Diploma in Biology from Technical University of Darmstadt.